Cardiovascular disease prevention and dyslipidemia

被引：0
|
作者：
Malmartel, Alexandre [1 ,2 ]
机构：
[1] Univ Paris, Dept Med Gen, F-75014 Paris, France
[2] Univ Paris, Methods Team, Ctr Res Epidemiol & Stat Cress, INRA,INSERM, F-75004 Paris, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2021年 / 177期
关键词：
STATIN THERAPY; CHOLESTEROL; ASSOCIATION; MORTALITY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：415 / 417
页数：3
相关论文
共 50 条
  • [31] SmartLab 2.0 in cardiovascular prevention of atherogenic dyslipidemia
    Toribio, Raquel Galvan
    Velilla, Teresa Arrobas
    Porillo, Cristobal Morales
    Rico, Miguel Angel
    Quesada, Mar Martinez
    Justel, Antonio Leon
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2023, 35 (03): : 123 - 128
  • [32] 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
    Anderson, Todd J.
    Gregoire, Jean
    Hegele, Robert A.
    Couture, Patrick
    Mancini, G. B. John
    McPherson, Ruth
    Francis, Gordon A.
    Poirier, Paul
    Lau, David C.
    Grover, Steven
    Genest, Jacques, Jr.
    Carpentier, Andre C.
    Dufour, Robert
    Gupta, Milan
    Ward, Richard
    Leiter, Lawrence A.
    Lonn, Eva
    Ng, Dominic S.
    Pearson, Glen J.
    Yates, Gillian M.
    Stone, James A.
    Ur, Ehud
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (02) : 151 - 167
  • [33] Kidney disease and cardiovascular disease: Implications of dyslipidemia
    Keane, WF
    Lyle, PA
    CARDIOLOGY CLINICS, 2005, 23 (03) : 363 - +
  • [34] Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options
    Berman, Adam N.
    Blankstein, Ron
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (09)
  • [35] Formalized interconnected guidelines on cardiovascular disease prevention and those for management of diabetes, dyslipidemia and hypertension
    Peleska, J.
    Anger, Z.
    Buchtela, D.
    Tomeckova, M.
    Vesely, A.
    Zvarova, J.
    JOURNAL OF HYPERTENSION, 2006, 24 : S172 - S172
  • [36] Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options
    Adam N. Berman
    Ron Blankstein
    Current Cardiology Reports, 2019, 21
  • [37] Secondary Prevention for Atherosclerotic Cardiovascular Disease Comparing Recent US and European Guidelines on Dyslipidemia
    Virani, Salim S.
    Smith, Sidney C., Jr.
    Stone, Neil J.
    Grundy, Scott M.
    CIRCULATION, 2020, 141 (14) : 1121 - 1123
  • [38] Categories of dyslipidemia and risk of cardiovascular disease
    Wilson, PW
    D'Agostino, RB
    Nam, BH
    Schaefer, EJ
    CIRCULATION, 2005, 111 (14) : E236 - E236
  • [39] Dyslipidemia and cardiovascular disease in Japanese women
    Iso, Hiroyasu
    JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 2007, 28 : 7 - 7
  • [40] Cardiovascular Disease and Dyslipidemia: Beyond LDL
    Poess, Janine
    Custodis, Florian
    Werner, Christian
    Weingaertner, Oliver
    Boehm, Michael
    Laufs, Ulrich
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) : 861 - 870
12345